These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36139430)

  • 1. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
    You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.
    You GR; Cheng AJ; Shen EY; Fan KH; Huang YF; Huang YC; Chang KP; Chang JT
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.
    You GR; Chang JT; Li YL; Chen YJ; Huang YC; Fan KH; Chen YC; Kang CJ; Cheng AJ
    Front Oncol; 2021; 11():681717. PubMed ID: 34307149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug resistance-associated protein 1 mediates 15-deoxy-Δ(12,14)-prostaglandin J2-induced expression of glutamate cysteine ligase expression via Nrf2 signaling in human breast cancer cells.
    Song NY; Kim DH; Kim EH; Na HK; Kim NJ; Suh YG; Surh YJ
    Chem Res Toxicol; 2011 Aug; 24(8):1231-41. PubMed ID: 21728338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDF15 contributes to radioresistance and cancer stemness of head and neck cancer by regulating cellular reactive oxygen species via a SMAD-associated signaling pathway.
    Li YL; Chang JT; Lee LY; Fan KH; Lu YC; Li YC; Chiang CH; You GR; Chen HY; Cheng AJ
    Oncotarget; 2017 Jan; 8(1):1508-1528. PubMed ID: 27903972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteasome inhibition induces a p38 MAPK pathway-dependent antiapoptotic program via Nrf2 in thyroid cancer cells.
    Du ZX; Yan Y; Zhang HY; Liu BQ; Gao YY; Niu XF; Meng X; Wang HQ
    J Clin Endocrinol Metab; 2011 May; 96(5):E763-71. PubMed ID: 21346076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
    Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
    J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vanadate oxidative and apoptotic effects are mediated by the MAPK-Nrf2 pathway in layer oviduct magnum epithelial cells.
    Wang J; Huang X; Zhang K; Mao X; Ding X; Zeng Q; Bai S; Xuan Y; Peng H
    Metallomics; 2017 Nov; 9(11):1562-1575. PubMed ID: 29022012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic role of baicalein in combating experimental periodontitis with diabetes via Nrf2 antioxidant signaling pathway.
    Zhu C; Zhao Y; Wu X; Qiang C; Liu J; Shi J; Gou J; Pei D; Li A
    J Periodontal Res; 2020 Jun; 55(3):381-391. PubMed ID: 31854466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer.
    Kim EH; Jang H; Shin D; Baek SH; Roh JL
    Apoptosis; 2016 Nov; 21(11):1265-1278. PubMed ID: 27544755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy.
    Zhong Q; Mishra M; Kowluru RA
    Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):3941-8. PubMed ID: 23633659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
    Deng X; Rui W; Zhang F; Ding W
    Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway.
    Lin X; Bai D; Wei Z; Zhang Y; Huang Y; Deng H; Huang X
    PLoS One; 2019; 14(5):e0216711. PubMed ID: 31112588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia.
    Ungvari Z; Bailey-Downs L; Gautam T; Jimenez R; Losonczy G; Zhang C; Ballabh P; Recchia FA; Wilkerson DC; Sonntag WE; Pearson K; de Cabo R; Csiszar A
    Am J Physiol Heart Circ Physiol; 2011 Apr; 300(4):H1133-40. PubMed ID: 21217061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.
    Koyani CN; Kitz K; Rossmann C; Bernhart E; Huber E; Trummer C; Windischhofer W; Sattler W; Malle E
    Biochem Pharmacol; 2016 Mar; 104():29-41. PubMed ID: 26801686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of the Glutathione, Thioredoxin, and Nrf2 Antioxidant Systems in Head and Neck Cancer.
    Roh JL; Jang H; Kim EH; Shin D
    Antioxid Redox Signal; 2017 Jul; 27(2):106-114. PubMed ID: 27733046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-MYC-directed NRF2 drives malignant progression of head and neck cancer via glucose-6-phosphate dehydrogenase and transketolase activation.
    Tang YC; Hsiao JR; Jiang SS; Chang JY; Chu PY; Liu KJ; Fang HL; Lin LM; Chen HH; Huang YW; Chen YT; Tsai FY; Lin SF; Chuang YJ; Kuo CC
    Theranostics; 2021; 11(11):5232-5247. PubMed ID: 33859744
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.